InvestorsHub Logo
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

Re: invest2win post# 180

Thursday, 05/19/2011 11:23:37 AM

Thursday, May 19, 2011 11:23:37 AM

Post# of 320

$20 Target !!


Canaccord Genuity Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Model Revisions Ahead of DIFICID Launch

Canaccord Genuity reiterates a 'Buy' on Optimer Pharmaceuticals (NASDAQ: OPTR), PT $20.